scholarly journals Psychotropic Drug Use in Children with Autism Spectrum Disorder Admitted to a Training and Research Hospital Outpatient Clinic: A Retrospective Cross-Sectional Study

2020 ◽  
Vol 10 (01) ◽  
pp. e233-e239
Author(s):  
Sabide Duygu Uygun ◽  
Fatma Hülya Çakmak ◽  
Merve Canlı ◽  
Rahime Duygu Temeltürk ◽  
Ayşegül Efe ◽  
...  
Keyword(s):  
Drug Use ◽  
Psychotropic Drug ◽  
Children With Autism ◽  
Autism Spectrum ◽  
Psychiatric Comorbidities ◽  
Research Hospital ◽  
Clinical Variables ◽  
Hospital Outpatient Clinic ◽  
Psychotropic Drug Use ◽  
Training And Research

AbstractThis study aimed to examine demographic and clinical variables, psychiatric comorbidities, the prevalence of psychotropic drug use, relationships between drug use, demographic and clinical variables, and predictors of drug use in children with autism spectrum disorder (ASD) admitted to a training and research hospital outpatient clinic. Four hundred and eleven children with ASD admitted to the Department of Child and Adolescent Psychiatry, Dr. Sami Ulus Maternity and Children's Health and Diseases Training and Research Hospital, between October 1, 2019 and December 31, 2019, were retrospectively reviewed. Demographic and clinical variables, psychiatric comorbidities, and characteristics of drug use for the cases were recorded. Psychotropic drug use was found in 34.3% (n = 141) of the cases. Our results revealed male sex and psychiatric comorbidity as predictors of psychotropic drug use. Antipsychotics were the most prescribed drugs, and the most common psychiatric comorbidity was conduct disorder. Also, children with ASD who had been toilet-trained, and could express sentences but were illiterate, were using psychotropic drugs more often than others. Future multicentered, large clinic-based studies from training and research hospitals should focus on trends of treatment in psychiatric comorbidities accompanying ASD, and constitute a systematic approach for the psychopharmacological treatment of these cases.

scholarly journals Use of Psychotropic Drugs among Children and Adolescents with Autism Spectrum Disorders in Denmark: A Nationwide Drug Utilization Study

2018 ◽  
Vol 7 (10) ◽  
pp. 339 ◽  
Author(s):  
Lotte Rasmussen ◽  
Niels Bilenberg ◽  
Martin Thomsen Ernst ◽  
Sidsel Abitz Boysen ◽  
Anton Pottegård
Keyword(s):  
Drug Use ◽  
Children And Adolescents ◽  
Psychotropic Drug ◽  
Treatment Initiation ◽  
Autism Spectrum ◽  
Adhd Medication ◽  
Long Term Effects ◽  
Children With Asd ◽  
Psychotropic Drug Use ◽  
Drug Classes

Children with autism spectrum disorder (ASD) have a considerable use of psychotropics. Leveraging nationwide registry data, we aimed to describe the use of psychotropics among children and adolescents with ASD in Denmark. Use of melatonin and attention-deficit/hyperactivity disorder (ADHD) medication increased from 2010 to 2017, while there were limited changes in use of antidepressants and antipsychotics. Thirty percent of the identified children used psychotropics in 2017 most commonly ADHD medication (17%) and melatonin (13%). Methylphenidate, sertraline and risperidone were most often prescribed. Most children filled more than one prescription and, across drug classes, at least 38% received treatment two years after treatment initiation. Use of psychotropics followed psychiatric comorbidities. Comorbidities did not affect age at treatment initiation. Use of psychotropics varied according to age and sex with limited use in the youngest children. In summary, psychotropic drug use has increased in children with ASD mainly due to an increase in the use of ADHD medication and melatonin. In accordance with previous studies, use seems to follow comorbidities. The long treatment duration underlines the need to investigate long-term effects of psychotropic drug use in children with ASD.

scholarly journals Are There Racial Disparities in Psychotropic Drug Use and Expenditures in a Nationally Representative Sample of Men in the United States? Evidence From the Medical Expenditure Panel Survey

2013 ◽  
Vol 8 (1) ◽  
pp. 82-90 ◽  
Author(s):  
Geraldine Pierre ◽  
Roland J. Thorpe ◽  
Gniesha Y. Dinwiddie ◽  
Darrell J. Gaskin
Keyword(s):  
United States ◽  
Drug Use ◽  
Racial Disparities ◽  
Psychotropic Drug ◽  
Medical Expenditure Panel Survey ◽  
The United States ◽  
Medical Expenditure ◽  
Panel Survey ◽  
Psychotropic Drug Use ◽  
Nationally Representative

This article sought to determine whether racial disparities exist in psychotropic drug use and expenditures in a nationally representative sample of men in the United States. Data were extracted from the 2000-2009 Medical Expenditure Panel Survey, a longitudinal survey that covers the U.S. civilian noninstitutionalized population. Full-Year Consolidated, Medical Conditions, and Prescribed Medicines data files were merged across 10 years of data. The sample of interest was limited to adult males aged 18 to 64 years, who reported their race as White, Black, Hispanic, or Asian. This study employed a pooled cross-sectional design and a two-part probit generalized linear model for analyses. Minority men reported a lower probability of psychotropic drug use (Black = −4.3%, 95% confidence interval [CI] = [−5.5, −3.0]; Hispanic = −3.8%, 95% CI = [−5.1, −2.6]; Asian = −4.5%, 95% CI = [−6.2, −2.7]) compared with White men. After controlling for demographic, socioeconomic, and health status variables, there were no statistically significant race differences in drug expenditures. Consistent with previous literature, racial and ethnic disparities in the use of psychotropic drugs present problems of access to mental health care and services.

scholarly journals Psychotropic drug use among people with dementia – a six-month follow-up study

2013 ◽  
Vol 14 (1) ◽  
Author(s):  
Maria Gustafsson ◽  
Stig Karlsson ◽  
Yngve Gustafson ◽  
Hugo Lövheim
Keyword(s):  
Drug Use ◽  
Psychotropic Drug ◽  
Follow Up Study ◽  
Psychotropic Drug Use ◽  
People With Dementia

scholarly journals Incarceration and Psychotropic Drug Use by Youth

2008 ◽  
Vol 162 (3) ◽  
pp. 219 ◽  
Author(s):  
Alison Evans Cuellar ◽  
Kelly J. Kelleher ◽  
Sheryl Kataoka ◽  
Steven Adelsheim ◽  
Joseph J. Cocozza
Keyword(s):  
Drug Use ◽  
Psychotropic Drug ◽  
Psychotropic Drug Use
Sign in / Sign up

Export Citation Format

Share Document